Campbell Bradley L 4
4 · AMICUS THERAPEUTICS, INC. · Filed Dec 17, 2025
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-15$9.03/sh+70,426$635,947→ 1,207,708 total - Sale
Common Stock
2025-12-15$10.86/sh−77,926$846,011→ 1,129,782 total - Exercise/Conversion
Stock Options (right to buy)
2025-12-15−70,426→ 0 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (70,426 underlying)
Footnotes (2)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.60 to $11.11 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]All of the options were fully vested and exercisable as of the transaction date.